Novel inhibitors of 5α-reductase

Author： Machetti Fabrizio   Guarna Antonio  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.2, 2002-02, pp. : 201-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Steroid 5-Reductase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-05 ,pp. : 225-237

Bentham Science Publishers

Access to resources Recommend Favorite

Benefits of long-term α-blockers + 5-α-reductase inhibitors

By  

Inpharma, Vol. 1, Iss. 1572, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

A Review on Steroidal 5-Reductase Inhibitors for Treatment of Benign Prostatic Hyperplasia

By  

Current Medicinal Chemistry, Vol. 18, Iss. 23, 2011-08 ,pp. : 3576-3589

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Antiproliferative Activity of 3-aza Steroids as 5-reductase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 11, 2017-10 ,pp. : 1335-1346

Bentham Science Publishers

Access to resources Recommend Favorite

Dutasteride: a novel dual inhibitor of 5α-reductase for benign prostatic hyperplasia

By Djavan Bob   Milani Shirin   Fong Yan Kit  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite